BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Taylor CM, White RH, Winterborn MH, Rowe B. Haemolytic-uraemic syndrome: clinical experience of an outbreak in the West Midlands. Br Med J (Clin Res Ed) 1986;292:1513-6. [PMID: 3087499 DOI: 10.1136/bmj.292.6534.1513] [Cited by in Crossref: 72] [Cited by in F6Publishing: 69] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Thomas LV, Wimpenny JW, G.davis J. Effect of three preservatives on the growth of Bacillus cereus, Vero cytotoxigenic Escherichia coli and Staphylococcus aureus, on plates with gradients of pH and sodium chloride concentration. International Journal of Food Microbiology 1993;17:289-301. [DOI: 10.1016/0168-1605(93)90199-q] [Cited by in Crossref: 30] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
2 Obrig T, Del Vecchio P, Karmali M, Petric M, Moran T, Judge T. PATHOGENESIS OF HAEMOLYTIC URAEMIC SYNDROME. The Lancet 1987;330:687. [DOI: 10.1016/s0140-6736(87)92473-1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
3 Morgan GM, Newman C, Palmer SR, Allen JB, Shepherd W, Rampling AM, Warren RE, Gross RJ, Scotland SM, Smith HR. First recognized community outbreak of haemorrhagic colitis due to verotoxin-producing Escherichia coli O 157.H7 in the UK. Epidemiol Infect 1988;101:83-91. [PMID: 3042441 DOI: 10.1017/s0950268800029241] [Cited by in Crossref: 69] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
4 Obata F, Hippler LM, Saha P, Jandhyala DM, Latinovic OS. Shiga toxin type-2 (Stx2) induces glutamate release via phosphoinositide 3-kinase (PI3K) pathway in murine neurons. Front Mol Neurosci 2015;8:30. [PMID: 26236186 DOI: 10.3389/fnmol.2015.00030] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
5 Milford D, Taylor C. HYPONATRAEMIA AND HAEMOLYTIC URAEMIC SYNDROME. The Lancet 1989;333:439. [DOI: 10.1016/s0140-6736(89)90033-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
6 Obata F. Influence of Escherichia coli Shiga Toxin on the Mammalian Central Nervous System. Elsevier; 2010. pp. 1-19. [DOI: 10.1016/s0065-2164(10)71001-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
7 Pennington T. VTEC: lessons learned from British outbreaks. Journal of Applied Microbiology 2000;88:90S-8S. [DOI: 10.1111/j.1365-2672.2000.tb05336.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
8 Greig DR, Mikhail AFW, Dallman TJ, Jenkins C. Analysis Shiga Toxin-Encoding Bacteriophage in a Rare Strain of Shiga Toxin-Producing Escherichia coli O157:H7 stx2a/stx2c. Front Microbiol 2020;11:577658. [PMID: 33193199 DOI: 10.3389/fmicb.2020.577658] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Neild GH. Haemolytic-uraemic syndrome in practice. Lancet 1994;343:398-401. [PMID: 7905557 DOI: 10.1016/s0140-6736(94)91228-9] [Cited by in Crossref: 56] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
10 Lamont PM, Davidson AI. Haemolytic-uraemic syndrome presenting as an acute abdomen. Postgrad Med J 1987;63:807-9. [PMID: 3444808 DOI: 10.1136/pgmj.63.743.807] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
11 Serna A, Boedeker EC. Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections: . Current Opinion in Gastroenterology 2008;24:38-47. [DOI: 10.1097/mog.0b013e3282f2dfb8] [Cited by in Crossref: 81] [Cited by in F6Publishing: 36] [Article Influence: 5.8] [Reference Citation Analysis]
12 Thomas A, Chart H, Cheasty T, Smith HR, Frost JA, Rowe B. Vero cytotoxin-producing Escherichia coli, particularly serogroup O 157, associated with human infections in the United Kingdom: 1989-91. Epidemiol Infect 1993;110:591-600. [PMID: 8519324 DOI: 10.1017/s0950268800051013] [Cited by in Crossref: 63] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
13 Andreoli S, Bergstein J. Exocrine and endocrine pancreatic insufficiency and calcinosis after hemolytic uremic syndrome. The Journal of Pediatrics 1987;110:816-7. [DOI: 10.1016/s0022-3476(87)80035-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
14 Ullrich S, Bremer P, Neumann-Grutzeck C, Otto H, Rüther C, von Seydewitz CU, Meyer GP, Ahmadi-Simab K, Röther J, Hogan B, Schwenk W, Fischbach R, Caselitz J, Puttfarcken J, Huggett S, Tiedeken P, Pober J, Kirkiles-Smith NC, Hagenmüller F. Symptoms and clinical course of EHEC O104 infection in hospitalized patients: a prospective single center study. PLoS One 2013;8:e55278. [PMID: 23460784 DOI: 10.1371/journal.pone.0055278] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
15 Kleanthous H, Fry NK, Smith HR, Gross RJ, Rowe B. The use of sorbitol-MacConkey agar in conjunction with a specific antiserum for the detection of Vero cytotoxin-producing strains of Escherichia coli O 157. Epidemiol Infect 1988;101:327-35. [PMID: 3053220 DOI: 10.1017/s0950268800054261] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
16 Pinto A, Jacobsen M, Geoghegan PA, Cangelosi A, Cejudo ML, Tironi-Farinati C, Goldstein J. Dexamethasone rescues neurovascular unit integrity from cell damage caused by systemic administration of shiga toxin 2 and lipopolysaccharide in mice motor cortex. PLoS One 2013;8:e70020. [PMID: 23894578 DOI: 10.1371/journal.pone.0070020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
17 Frost JA, Cheasty T, Thomas A, Rowe B. Phage typing of Vero cytotoxin-producing Escherichia coli O 157 isolated in the United Kingdom: 1989-91. Epidemiol Infect 1993;110:469-75. [PMID: 8519312 DOI: 10.1017/s0950268800050895] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
18 Dallman TJ, Ashton PM, Byrne L, Perry NT, Petrovska L, Ellis R, Allison L, Hanson M, Holmes A, Gunn GJ, Chase-Topping ME, Woolhouse MEJ, Grant KA, Gally DL, Wain J, Jenkins C. Applying phylogenomics to understand the emergence of Shiga-toxin-producing Escherichia coli O157:H7 strains causing severe human disease in the UK. Microb Genom 2015;1:e000029. [PMID: 28348814 DOI: 10.1099/mgen.0.000029] [Cited by in Crossref: 54] [Cited by in F6Publishing: 62] [Article Influence: 7.7] [Reference Citation Analysis]
19 Cheasty T, Robertson R, Chart H, Mannion P, Syed Q, Garvey R, Rowe B. The use of serodiagnosis in the retrospective investigation of a nursery outbreak associated with Escherichia coli O157:H7. J Clin Pathol 1998;51:498-501. [PMID: 9797724 DOI: 10.1136/jcp.51.7.498] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
20 Salmon RL, Farrell ID, Hutchison JG, Coleman DJ, Gross RJ, Fry NK, Rowe B, Palmer SR. A christening party outbreak of haemorrhagic colitis and haemolytic uraemic syndrome associated with Escherichia coli O 157.H7. Epidemiol Infect 1989;103:249-54. [PMID: 2680545 DOI: 10.1017/s0950268800030600] [Cited by in Crossref: 40] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
21 Robson WL, Leung AK, Kaplan BS. Hemolytic-uremic syndrome. Curr Probl Pediatr 1993;23:16-33. [PMID: 8453889 DOI: 10.1016/0045-9380(93)90027-a] [Cited by in Crossref: 28] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
22 Frost JA, Smith HR, Willshaw GA, Scotland SM, Gross RJ, Rowe B. Phage-typing of Vero-cytotoxin (VT) producing Escherichia coli O157 isolated in the United Kingdom. Epidemiol Infect 1989;103:73-81. [PMID: 2673827 DOI: 10.1017/s0950268800030375] [Cited by in Crossref: 29] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
23 Coia JE, Sharp JC, Campbell DM, Curnow J, Ramsay CN. Environmental risk factors for sporadic Escherichia coli O157 infection in Scotland: results of a descriptive epidemiology study. J Infect 1998;36:317-21. [PMID: 9661944 DOI: 10.1016/s0163-4453(98)94423-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
24 Loneragan G, Brashears M. Pre-harvest interventions to reduce carriage of E. coli O157 by harvest-ready feedlot cattle. Meat Science 2005;71:72-8. [DOI: 10.1016/j.meatsci.2005.04.005] [Cited by in Crossref: 79] [Cited by in F6Publishing: 65] [Article Influence: 4.6] [Reference Citation Analysis]
25 Jenkins C, Dallman TJ, Grant KA. Impact of whole genome sequencing on the investigation of food-borne outbreaks of Shiga toxin-producing Escherichia coli serogroup O157:H7, England, 2013 to 2017. Euro Surveill 2019;24. [PMID: 30696532 DOI: 10.2807/1560-7917.ES.2019.24.4.1800346] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
26 Green DA, Murphy WG, Uttley WS. Haemolytic uraemic syndrome: prognostic factors. Clin Lab Haematol 2000;22:11-4. [PMID: 10762298 DOI: 10.1046/j.1365-2257.2000.00272.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
27 Adams NL, Byrne L, Smith GA, Elson R, Harris JP, Salmon R, Smith R, O'Brien SJ, Adak GK, Jenkins C. Shiga Toxin-Producing Escherichia coli O157, England and Wales, 1983-2012. Emerg Infect Dis 2016;22:590-7. [PMID: 26982243 DOI: 10.3201/eid2204.151485] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 7.0] [Reference Citation Analysis]
28 Chart H. Are all infections with Escherichia coli O157 associated with cattle? Lancet 1998;352:1005. [PMID: 9759740 DOI: 10.1016/S0140-6736(05)60072-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
29 Seifert ME, Tarr PI. Azithromycin decolonization of STEC—a new risk emerges. Nat Rev Nephrol 2012;8:429-429. [DOI: 10.1038/nrneph.2012.87-c1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
30 Milley DG, Sekla LH. An enzyme-linked immunosorbent assay-based isolation procedure for verotoxigenic Escherichia coli. Appl Environ Microbiol 1993;59:4223-9. [PMID: 8285713 DOI: 10.1128/aem.59.12.4223-4229.1993] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
31 Kleanthous H, Smith HR, Scotland SM, Gross RJ, Rowe B, Taylor CM, Milford DV. Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects. Arch Dis Child 1990;65:722-7. [PMID: 2201262 DOI: 10.1136/adc.65.7.722] [Cited by in Crossref: 140] [Cited by in F6Publishing: 140] [Article Influence: 4.4] [Reference Citation Analysis]
32 Karmali MA. Infection by verocytotoxin-producing Escherichia coli. Clin Microbiol Rev 1989;2:15-38. [PMID: 2644022 DOI: 10.1128/CMR.2.1.15] [Cited by in Crossref: 922] [Cited by in F6Publishing: 280] [Article Influence: 27.9] [Reference Citation Analysis]
33 Al-Jader L, Salmon RL, Walker AM, Williams HM, Willshaw GA, Cheasty T. Outbreak of Escherichia coli O157 in a nursery: lessons for prevention. Arch Dis Child 1999;81:60-3. [PMID: 10373138 DOI: 10.1136/adc.81.1.60] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.2] [Reference Citation Analysis]
34 Olah KS, Gee H. Postpartum haemolytic uraemic syndrome precipitated by antibiotics. Case report. BJOG:An international journal of O&G 1990;97:83-6. [DOI: 10.1111/j.1471-0528.1990.tb01722.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
35 Abu-Arafeh I, Gray E, Youngson G, Auchterlonie I, Russell G. Myocarditis and haemolytic uraemic syndrome. Arch Dis Child 1995;72:46-7. [PMID: 7717737 DOI: 10.1136/adc.72.1.46] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 0.9] [Reference Citation Analysis]
36 Loirat C, Sonsino E, Hinglais N, Jais JP, Landais P, Fermanian J; French Society of Paediatric Nephrology. Treatment of the childhood haemolytic uraemic syndrome with plasma: A multicentre randomized controlled trial. Pediatr Nephrol 1988;2:279-85. [DOI: 10.1007/bf00858677] [Cited by in Crossref: 73] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
37 Askiti V, Hendrickson K, Fish AJ, Braunlin E, Sinaiko AR. Troponin I levels in a hemolytic uremic syndrome patient with severe cardiac failure. Pediatr Nephrol 2004;19:345-8. [PMID: 14685841 DOI: 10.1007/s00467-003-1343-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
38 Chapman P. Verocytotoxin-producing Escherichia coli: an overview with emphasis on the epidemiology and prospects for control of E. coli O157. Food Control 1995;6:187-93. [DOI: 10.1016/0956-7135(95)00014-i] [Cited by in Crossref: 8] [Article Influence: 0.3] [Reference Citation Analysis]
39 Milford DV, Taylor CM, Guttridge B, Hall SM, Rowe B, Kleanthous H. Haemolytic uraemic syndromes in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli. Part 1: Clinical and epidemiological aspects. Arch Dis Child 1990;65:716-21. [PMID: 2201261 DOI: 10.1136/adc.65.7.716] [Cited by in Crossref: 115] [Cited by in F6Publishing: 108] [Article Influence: 3.6] [Reference Citation Analysis]
40 Iijima K, Kamioka I, Nozu K. Management of diarrhea-associated hemolytic uremic syndrome in children. Clin Exp Nephrol 2008;12:16-9. [DOI: 10.1007/s10157-007-0007-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
41 Butt S, Smith-Palmer A, Shand A, McDonald E, Allison L, Maund J, Fernandes A, Vishram B, Greig DR, Jenkins C, Elson R; Outbreak Control Team. Evidence of on-going transmission of Shiga toxin-producing Escherichia coli O157:H7 following a foodborne outbreak. Epidemiol Infect 2021;149:e147. [PMID: 34096488 DOI: 10.1017/S0950268821001278] [Reference Citation Analysis]
42 Dallman TJ, Greig DR, Gharbia SE, Jenkins C. Phylogenetic structure of Shiga toxin-producing Escherichia coli O157:H7 from sub-lineage to SNPs. Microb Genom 2021;7. [PMID: 33720818 DOI: 10.1099/mgen.0.000544] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Obata F, Tohyama K, Bonev AD, Kolling GL, Keepers TR, Gross LK, Nelson MT, Sato S, Obrig TG. Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons. J Infect Dis 2008;198:1398-406. [PMID: 18754742 DOI: 10.1086/591911] [Cited by in Crossref: 70] [Cited by in F6Publishing: 61] [Article Influence: 5.0] [Reference Citation Analysis]
44 Robson WLM, Leung AKC. HYPERGLYCAEMIA IN CHILDREN WITH HAEMOLYTIC URAEMIC SYNDROME. J Paediatr Child Health 1991;27:64a-65. [DOI: 10.1111/j.1440-1754.1991.tb00351.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
45 Yara DA, Greig DR, Gally DL, Dallman TJ, Jenkins C. Comparison of Shiga toxin-encoding bacteriophages in highly pathogenic strains of Shiga toxin-producing Escherichia coli O157:H7 in the UK. Microb Genom 2020;6. [PMID: 32100710 DOI: 10.1099/mgen.0.000334] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
46 Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet. 2005;365:1073-1086. [PMID: 15781103 DOI: 10.1016/s0140-6736(05)71144-2] [Cited by in Crossref: 269] [Cited by in F6Publishing: 536] [Article Influence: 15.8] [Reference Citation Analysis]
47 Wiwanitkit V. Outbreak of Escherichia coli and diabetes mellitus. Indian J Endocrinol Metab 2011;15:S70-1. [PMID: 21847464 DOI: 10.4103/2230-8210.83050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
48 Schmitt CK, Mckee ML, O'brien AD. Two copies of Shiga-like toxin II-related genes common in enterohemorrhagic Escherichia coli strains are responsible for the antigenic heterogeneity of the O157:H- strain E32511. Infect Immun 1991;59:1065-73. [DOI: 10.1128/iai.59.3.1065-1073.1991] [Cited by in Crossref: 185] [Cited by in F6Publishing: 104] [Article Influence: 6.0] [Reference Citation Analysis]
49 Kavaliauskiene S, Dyve Lingelem AB, Skotland T, Sandvig K. Protection against Shiga Toxins. Toxins (Basel) 2017;9:E44. [PMID: 28165371 DOI: 10.3390/toxins9020044] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 7.6] [Reference Citation Analysis]
50 Hunt CM, Harvey JA, Youngs ER, Irwin ST, Reid TM. Clinical and pathological variability of infection by enterohaemorrhagic (Vero cytotoxin producing) Escherichia coli. J Clin Pathol 1989;42:847-52. [PMID: 2671052 DOI: 10.1136/jcp.42.8.847] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
51 Scotland SM, Willshaw GA, Smith HR, Rowe B. Properties of strains of Escherichia coli belonging to serogroup O157 with special reference to production of Vero cytotoxins VT1 and VT2. Epidemiol Infect 1987;99:613-24. [PMID: 3322851 DOI: 10.1017/s0950268800066462] [Cited by in Crossref: 111] [Cited by in F6Publishing: 42] [Article Influence: 3.3] [Reference Citation Analysis]
52 Vanaja SK, Jandhyala DM, Mallick EM, Leong JM, Balasubramanian S. Enterohemorrhagic and other Shigatoxin-producing Escherichia coli. Escherichia coli. Elsevier; 2013. pp. 121-82. [DOI: 10.1016/b978-0-12-397048-0.00005-x] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
53 Hughes D, Beattie T, Murphy A. Haemolytic Uraemic Syndrome: 17 Years' Experience in a Scottish Paediatric Renal Unit. Scott Med J 1991;36:9-12. [DOI: 10.1177/003693309103600105] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
54 Šrámková L, Bielaszewská M, Janda J, Bláhová K, Hausner O. Vero cytotoxin-producing strains of Escherichia coli in children with haemolytic uraemic syndrome and diarrhoea in Czechoslovakia. Infection 1990;18:204-9. [DOI: 10.1007/bf01643386] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
55 Nester CM. Multifaceted hemolytic uremic syndrome in pediatrics. Blood Purif 2013;35:86-92. [PMID: 23343552 DOI: 10.1159/000346486] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
56 Siegler RL. Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome. J Pediatr 1994;125:511-8. [PMID: 7931868 DOI: 10.1016/s0022-3476(94)70001-x] [Cited by in Crossref: 128] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
57 Sharp JC, Ritchie LD, Curnow J, Reid TM. High incidence of haemorrhagic colitis due to Escherichia coli O157 in one Scottish town: clinical and epidemiological features. J Infect 1994;29:343-50. [PMID: 7884230 DOI: 10.1016/s0163-4453(94)91381-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
58 Milford DV, Taylor CM. New insights into the haemolytic uraemic syndromes. Arch Dis Child 1990;65:713-5. [PMID: 2201260 DOI: 10.1136/adc.65.7.713] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
59 Kavi J, Wise R. Causes of the haemolytic uraemic syndrome. BMJ 1989;298:65-6. [PMID: 2493295 DOI: 10.1136/bmj.298.6666.65] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
60 Alexopoulou A, Dourakis SP, Zovoilis C, Agapitos E, Androulakis A, Filiotou A, Archimandritis AJ. Dilated cardiomyopathy during the course of hemolytic uremic syndrome. Int J Hematol 2007;86:333-6. [PMID: 18055340 DOI: 10.1532/IJH97.E0713] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
61 Zeidan SF, Coulthard MG. Transient glucose intolerance associated with the haemolytic-uraemic syndrome. Pediatr Nephrol 1987;1:605-7. [DOI: 10.1007/bf00853596] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
62 Chapman P. Verocytotoxin‐producing Escherichia coli 0157 infections. British Food Journal 1995;97:29-31. [DOI: 10.1108/00070709510104321] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
63 Pennington H. Escherichia coli O157. Lancet 2010;376:1428-35. [PMID: 20971366 DOI: 10.1016/S0140-6736(10)60963-4] [Cited by in Crossref: 254] [Cited by in F6Publishing: 103] [Article Influence: 21.2] [Reference Citation Analysis]
64 Dallman TJ, Greig DR, Gharbia SE, Jenkins C. Phylogenetic context of Shiga toxin-producing Escherichia coli serotype O26:H11 in England. Microb Genom 2019;7. [PMID: 33760723 DOI: 10.1099/mgen.0.000551] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
65 Piérard D, Etterijck R, Breynaert J, Moriau L, Lauwers S. Results of screening for verocytotoxin-producingEscherichia coli in faeces in Belgium. Eur J Clin Microbiol Infect Dis 1990;9:198-201. [DOI: 10.1007/bf01963837] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
66 Smith HR, Rowe B, Gross RJ, Fry NK, Scotland SM. Haemorrhagic colitis and Vero-cytotoxin-producing Escherichia coli in England and Wales. Lancet 1987;1:1062-5. [PMID: 2883398 DOI: 10.1016/s0140-6736(87)90485-5] [Cited by in Crossref: 79] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
67 Pennington TH. E. coli O157 outbreaks in the United Kingdom: past, present, and future. Infect Drug Resist 2014;7:211-22. [PMID: 25187729 DOI: 10.2147/IDR.S49081] [Cited by in Crossref: 28] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
68 Thomas A, Cheasty T, Frost JA, Chart H, Smith HR, Rowe B. Vero cytotoxin-producing Escherichia coli, particularly serogroup O157, associated with human infections in England and Wales: 1992-4. Epidemiol Infect 1996;117:1-10. [PMID: 8760944 DOI: 10.1017/s0950268800001060] [Cited by in Crossref: 50] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
69 Obata F, Obrig T. Distribution of Gb(3) Immunoreactivity in the Mouse Central Nervous System. Toxins (Basel) 2010;2:1997-2006. [PMID: 20725533 DOI: 10.3390/toxins2081997] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
70 Treacy J, Jenkins C, Paranthaman K, Jorgensen F, Mueller-Doblies D, Anjum M, Kaindama L, Hartman H, Kirchner M, Carson T, Kar-Purkayastha I. Outbreak of Shiga toxin-producing Escherichia coli O157:H7 linked to raw drinking milk resolved by rapid application of advanced pathogen characterisation methods, England, August to October 2017. Euro Surveill 2019;24. [PMID: 31014418 DOI: 10.2807/1560-7917.ES.2019.24.16.1800191] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 8.5] [Reference Citation Analysis]